Legend Biotech Corporation

NASDAQ: LEGN · Healthcare · Biotechnology

PublicHQ Somerset, NJ · SomersetCIK 0001801198Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH 64DQ —GM —SS 71

v0.1 · 35/100 weight · pillars only

↑ workforce scale, market scale · ↓ filing timeliness, listing tenure

Methodology →

Revenue TTM

$1.1B

Rev growth YoY (TTM)

+56.4%

Net income (FY)

-$296.8M

Employees

3,200

as of 2026-09-07

Market cap

$4.0B

as of 2026-09-07

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$296.8M-$296.8M2025

Total assets$1.7B$1.7B2025

Liabilities$731.6M$731.6M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Legend Biotech Corporation’s financial profile?

Legend Biotech Corporation earned -$296.8M in FY2025 net income.

Peers · Healthcare

Dyne Therapeutics, Inc.——Enliven Therapeutics, Inc.——Veradermics, Incorporated——Galera Therapeutics, Inc.——Vicore Pharma Holding AB——MBX Biosciences, Inc. Common Stock——

Neighbors

Somerset →

GPGI, Inc.——Freshpet, Inc.$1.1B76B+Peapack-Gladstone Financial Corporation$283.0M61C MCAP Inc.$104.7M61C SR Bancorp, Inc. Common stock——CareCloud, Inc.$120.5M73B

Key facts

CEOAlan S. Bash

SectorHealthcare

IndustryBiotechnology

HeadquartersSomerset, NJ

ExchangeNASDAQ: LEGN

Employees3,200

IPO date2020-06-05

Latest filings

6-K2026-06-22 6-K2026-06-15 6-K2026-06-02 6-K2026-06-01 6-K2026-05-21 6-K2026-05-12 6-K2026-04-14 20-F2026-03-10

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.